Close X
Attorney Spotlight

How did an interest in healthcare policy lead Robert Platt to a career in the law? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

Envision to Sell to KKR for $9.9 Billion

We represented Envision Healthcare Corporation (NYSE: EVHC) in its definitive agreement to sell to KKR in an all-cash transaction for $9.9 billion, including debt. KKR will pay $46 per Envision share in cash to buy the company, marking a 32 percent premium to the company's volume-weighted average share price from November 1, when Envision announced it was considering its options. The transaction is expected to close the fourth quarter of 2018. Read more


Envision Healthcare

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Six Things to Know Before Buying a Physician Practice spotlight

Dermatology, ophthalmology, radiology, urology…the list goes on. Yet, in any physician practice management transaction, there are six key considerations that apply and, if not carefully managed, can derail a transaction. Download the 6 Things to Know Before Buying a Physician Practice to keep your physician practice management transactions on track.

Click here to download the guide.

Richard Mattern Answers Questions on the Future of Medtech M&A

Medical Product Outsourcing

Publications

March 30, 2017

Bass, Berry & Sims attorney Richard Mattern answered questions for a Medical Product Outsourcing article detailing the future of the M&A space in 2017. Richard discussed the potential for 2017 to be a strong year for medical device M&A, due in part to near-complete integration efforts of prior years, allowing management to focus on pursuing opportunities. "Capital remains relatively accessible as interest rates remain at near historic lows, the IPO market remains choppy, significant cash is sitting on public balance sheets, and private equity continues to invest in the sector," Richard said. "The Trump administration appears committed to scaling back regulation, including the potential repeal of the medical device tax, and lowering corporate tax rates."

The full article, "A Legal Eye's View of Medtech M&A," was published by Medical Product Outsourcing on March 30, 2017, and is available online.


Related Professionals

Related Services

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.